New evidence supporting the assignment of glutamic acid as an iron ligand in hemerythrin by Gormley, Patricia M.
Portland State University
PDXScholar
Dissertations and Theses Dissertations and Theses
1978
New evidence supporting the assignment of glutamic acid as an
iron ligand in hemerythrin
Patricia M. Gormley
Portland State University
Let us know how access to this document benefits you.
Follow this and additional works at: http://pdxscholar.library.pdx.edu/open_access_etds
Part of the Chemistry Commons
This Thesis is brought to you for free and open access. It has been accepted for inclusion in Dissertations and Theses by an authorized administrator of
PDXScholar. For more information, please contact pdxscholar@pdx.edu.
Recommended Citation
Gormley, Patricia M., "New evidence supporting the assignment of glutamic acid as an iron ligand in hemerythrin" (1978).
Dissertations and Theses. Paper 2783.
10.15760/etd.2778
AN ABSTRACT OF THE THESIS OF Patricia Gormley for the Master of Science 
in Chemistry presented August 30, 1978. 
Title: New Evidence Supporting the Assignment of Glutamic Acid as an 
Iron·Ligand in Hemerythrin. 
APPROVED BY MEMBERS OF THE THESIS COMMITTEE: 
nn S. Loehr, Chairperson 
 
The amino acid sequence determination of Phascolopsis gouldii 
hemerythrin in the region of the proposed iron ligand at position 58 
was the main objective of this research endeavor. Generation of a large 
peptide was pursued by trypsin digestion of citraconylated hemerythrin 
producing peptide 50-113 for sequenator analysis. Detection of the 
phenylthiohydantoin amino acid derivatives by gas-liquid and high-per-
formance-liquid chromatography yielded unambiguous sequence elucidation 
through the region of interest identifying residue 58 as glutamic acid. 
Further specific digestion of peptide 50-113 by cyanogen bromide 
yielded peptides 50-62 and 63-113 which were chromatographically resolved 
I 
I· 
using Sephadex G-50 superfine. The identity of peptide 50-62 was verified 
by amino acid analysis. Sequenator analysis of this peptide substantiated 
the assignment of residue 58 as glutamic acid. 
Attempts to sequence peptide 54-74, derived from trypsin digestion 
of peptide 50-113, were frustrated in the ion exchange purification step. 
The peptide's high percentage of hydrophobic residues as well as its 
isoelectric form in the polar pyridine-acetate pH 5.0 buffer resulted in 
peptide insolubility. 
Identification of residue 58 as glutamic acid in Phascolopsis 
gouldii hemerythrin is significant in the.support it lends to the proposed 
model of the iron active site of Themiste dyscritum hemerythrin. 
i 
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INTRODUCTION 
Hemerythrin and myohemerythrin are non-heme iron proteins whose 
function is reversible oxygen binding. Invertebrate marine worms of the 
sipunculid phylum contain hemerythrin in their coelomic fluid and 
myohemerythrin in their muscle cells. Hemerythrin of the Atlantic coastal 
Phascolopsis (syn. Golfingia) gouldii is tje protein under investigation 
in this study. The protein is an octamer of molecular weight 108,000 
containing two iron atoms per monomer (1). 
IDENTIFICATION OF IRON LIGANDS 
c 
The x-ray crystal structure of r_. gouldii hemerythrin at 5.5 A 
resolution indicates that the two irons in each monomer are in close 
proximity and are coordinated by amino acid side chains from four, approxi-
mately parallel helices which comprise 70% of the protein structure (2). 
0 
A 2.8 A resolution crystal structure has been obtained for coelomic 
hemerythrin from a sipunculid indigenious to the Pacific coastal waters, 
Themiste (syn. Dendrostomum) dyscritum (3). The two iron atoms in the 
metaquo form of the T. dyscritum protein are in a trigonal antiprism with 
each iron octahedrally coordinated to five protein ligands (Fig. 1). 
Two of the ligands are common to both iron atoms and a third shared coor-
dination site contains a water molecule which is presumably replaced by 
oxygen in the native form of the protein. The iron binding site in 
f.. gouldii hemerythrin is very likely identical to that in I.· dyscritum 
hemerythrin as the two proteins exhibit similar spectroscopic properties 
(4) as well as similar protein conformations. 
his73 
hi~//hbn 
Fe /i' . 
;asp 106 J "- glu 58 
. ~\/ 
/\~ his 25 tyrfQg his 54 
Figure 1. Proposed model for0 the active site pf metaquo T. dyscritum hemerythrin at 2.8 A resolution (3). The same Tron 
ligands have been identified for myohemerythrin but with 
differing numbering (30). In the oxy form, the water is 
presumably replaced by 02 which is bound as the peroxide, 02 ( 31). 
2 
3 
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The 2.8 A resolution electron density map of l· dyscritum 
hemerythrin in conjunction with the protein's amino acid sequence (5) 
identified the iron ligands as His-25, His-54, Glu-58, His-74, His-77, 
His-101, Asp-106, and Tyr-109. These data were corroborated by the x-ray 
diffraction studies (6) and amino acid sequence (7) of myohemerythrin from 
l· zostericolum, another Pacific Coast sipunculid (formerly misidentified 
as T. pYroides). The amino acid sequence off_. gouldii hemerythrin (8) 
showed that seven of the amino acid ligand identities coincided. However, 
in the eighth ligand assignment, the sequences of T. dyscritum hemerythrin 
and T. zostericolum myohemerythrin indicated a glutamic acid at position 
58 while residue 58 off_. gouldii hemerythrin was identified as glutamine. 
The apparent lack of conservation of an iron ligand seemed unlikely and 
prompted the present investigation. 
This study was undertaken to more accurately determine the identity 
of the amino acid at position 58 in f_. gouldii hemerythrin. If glutamic 
acid proved to be the correct amino acid at residue 58, this would lend 
support to the trigonal antiprism model in which glutamic acid acts as 
one of the bridging ligands. However, should glutamine be verified as 
the amino acid at position 58, it would be the first example of glutamine 
as a metal ligand. It is known that amides have a low basicity and are, 
therefore, poor metal ligands (32). An active iron center containing 
an inferior ligand most probably would be disgarded by natural selection. 
The ~-carboxyl group of glutamic acid, however, is deprotonated above 
pH 4.2. Thus, there is a sound chemical basis for predicting glutamic 
acid as the correct iron ligand. 
AMINO ACID SEQUENCE DETERMINATION 
Facile elucidation of an amino acid sequence is attributable to 
the innovative automated protein sequenator of Edman and Begg (9). 
Utilization of the sequenator allows derivatization, cleavage and iso-
lation of amino acids sequentially from a peptide's NH2-terminus. The 
method emphasizes generation of a few large peptides from the parent 
protein instead of the many small peptides previously required for the 
manua) Edman degradation procedure. The requirement of few large 
peptides necessitates availability of highly specific cleavage agents 
or suitable blocking groups to hone an agent's specificity. 
Trypsin is an endopeptidase specific for cleavage at the COOH-
terminus of lysine and arginine. The enzyme's mode of action is illus-
trated in the following reaGtion: 
+ -+ H3N-R· · ·z-coo 
Trypsin is often contaminated with chymotrypsin, an enzyme that cleaves 
at the COOH-terminus of aromatic residues. Thus, trypsin preparations 
generally contain an inhibitor of chymotrypsin such as L-(tosyl-2-phenyl) 
chloroethyl methyl ketone (TPCK) to ensure an enzyme preparation of 
reliable specificity. 
For trypsin digestion it is beneficial to block cysteine residues 
since the presence of an acidic residue adjacent to arginine or lysine 
reduce~ the effective cleavage (10). Furthermore, blocking cysteine 
residues prevents oxidation of sulfhydryl groups to intra- or inter-
molecular disulfide moities which yield anomalous sequences. A blocking 
method of choice is represented by the reaction of 4-vinyl pyridine with 
a cysteinyl residue (11): 
I 
r=O -0 
cr-CH2-SH+CH2=CH ~ ;}N 
NH 
I 
CYSTEINE 4-VINYL PYRIDINE 
I 
C=O C~-CH2-S-CH2-cH2~N 
NH 
IPYRIDYLETHYL CYSTEINE 
5 
The protein subunit is reduced with dithiothreitol prior to reaction with 
4-vinyl pyridine since derivatization occurs only with the sulfhydryl 
form of cysteine. In the subsequent amino acid compos.ition a~d sequence 
determination, cysteine is detected as pyridylethyl cysteine. 
Derivatization of the E-amino group of lysine confers enhanced 
specificity on trypsin, such that it only cleaves after arginine. 
Citraconic anhydride is a blocking agent of choice due to the high 
solubility of its protein derivative at neutral pH and the ease of 
removal of the blocking group in acid. Lysine reacts with citraconic 
0 
CITRACONIC 
ANHYDRIDE 
I 
C=O 0 CH 
I II I 3 ---=>~ CHfCH2t4NH-C-CH=C-C00-+2H+ I 
NH 
I CITRACONYL PEPTIDE 
Other lysine blocking groups such as succinic anhydride and trifluoro-
acetic acid are less useful due to the difficulty of removal of the 
blocking group and solubility of the protein derivative, respectively (12). 
I 
I 
I. 
I 
Cyanogen bromide is known to specifically cleave the COOH-
terminal bond of methionine (13): 
~ I 
···CO-NH-CH-C-N-CHR ··· + Br-C:N ) 8 
CH2 
" 
CH2-S-CH3 
METHIONINE 
Br 
CYANOGEN 
BROMIDE 
> 
Br 
CYANOSULFONIUM INTERMEDIATE (I) 
+ Br-
·· ·CO-N-CH-C=NH-CHR 1 ···+CH -SCN 
/ ' 3 CH2 0 ~CH/ 
2 
. 6 
CYANOSULFONIUM INTERMEDIATE (I) IMINOLACTONE (II) METHYL THIOCYANATE 
~ + Br- H 0 2 · · ·CO- -CH-C=NH-CHR '·. · ........._ 
/""' \ --~-";;:7'~ 
CH 2 0 ~CH/ 
2 
H + 
···CO-N-CH-C=O + H N-CHR 1 ••• / \ 3 
CH 2 / ~H2 
IMINOLACTONE (II) PEPTIDYL HOMOSERINE LACTONE (III) 
The starting material is first reduced to convert any methionine sulfone 
or sulfoxide to methionine (14). Upon addition of CNBr, an unstable 
cyanosulfonium intermediate forms and then converts to the iminolactone 
(II) with elimination of the methyl thiocyanate as by-product. Hydrolysis 
of compound II produces the aminoacyl peptide and the peptidyl homoserine 
lactone. 
Once specific peptides are isolated and purified, degradation 
from the NH2-terminal is performed automatically in the sequenator 
designed by Edman and Begg (9). The method involves the following 
reaction scheme: 
COUPLING STEP 
7 
PHENYLISOTHIOCYANATE PHENYLTHIOCARBAMYL (PTC) PEPTIED (I) 
CYCLIZATION STEP 
PTC-PEPTIDE 
REARRANGEMENT STEP 
c6H5-NHC-S II I N C=O 
\ I CH 
I 
Rl 
ANILINO-THIAZOLINONE 
DERIVATIVE (II) 
ANILINO-THIAZOLINONE 
DERIVATIVE (II) 
PHENYLTHIOHYDANTOIN (PTH) 
DERIVATIVE (II I) 
The initial step involves formation of the phenyl thiocarbamyl derivative 
(I) which subsequently forms the thiazolinone (II) and peptide with a new 
NH 2-terminal. Once (II) is removed by extraction, the peptide is ready 
for another round of coupling and cyclization. The extracted compound 
(II) is slowly rearranged to the more stable PTH-amino acid (III) in 
an acid-catalyzed reaction. The resulting PTH amino acids are detected 
by gas-liquid and high-performance-liquid chromatography. These 
dete£tion methods offer greater sensitivity and accuracy than was pre-
viously possible with paper electrophoresis, thin-layer chromatography 
or amino acid analyzers. 
The methods outlined above, in conjunction with gel permeation 
and ion exchange chromatography, were used to produce peptides of 
purity suitable for unambiguous determination of the sequence in the 
region of residue 58 in .!:· gouldii hemerythrin. 
8 
EXPERIMENTAL PROCEDURES 
PREPARATION OF HEMERYTHRIN 
The sipunculid worm, Phascolopsis gouldii, was obtained from 
the Marine Biological Station in Woods Hole, Massachusetts. Erythrocytes, 
which contain hemerythrin, were separated from coelomic hemolymph, 
purified and lysed (15). Hemerythrin crystallization was effected by 
dialysis at 4oc against a 100-fold excess of 20% ethanol, 0.01 M sodium 
azide and 0.01 M Tris-Cl (tris hydroxymethyl-aminomethane) pH 7.5. 
Conversion of hemerythrin to the iron-free apo form was accomplished 
by the method of Loehr, et al. (5). 
CHEMICAL MODIFICATION OF HEMERYTHRIN 
Apohemerythrin was reacted with 4-vinyl _pyridine to covalently 
block cysteine and thus, stabilize the residue to oxidation (11). 
The hemerythrin modification procedure involved reduction of protein 
subunits which contain 3.7 µmoles cysteine with 0.12 mmole dithiothreitol, 
followed by reaction with 0.36 mmole 4-vinyl pyridine. Pyridylethylated 
hemerythrin and peptiaes were used in all subsequent reactions. The 
reaction was monitored by the presence of an absorbance maximum at 260 nm 
due to pyridylethly cysteine (16). 
Pyridylethylated hemerythrin was further modified to prevent 
trypsin digestion at lysyl residues by reaction with citraconic 
anhydride. Approximately 3.7 µmole of hemerythrin subunits containing 
f 
\ 
~-··· .. -· 1•"Wlll-l•-11-1--•111•11•1J•- I. l"!li• .-IR!l--•IL-.--------·---·- -··--··-··-----
! 
41 µmole lysine (17) were covalently blocked with 1.9 rrmole citraconic 
anhydride was vacuum distilled at 75oc and 2.5 mm Hg. Alkaline con-
ditions were maintained throughout the reaction and dialysis, as the 
citraconyl-lysyl bond is acid labile. 
SPECIFIC CLEAVAGE OF HEMERYTHRIN 
10 
Citraconylated pyridylethylated hemerythrin was digested specifically 
at the COOH-terminus of arginyl residues by TPCK-trypsin (5). The 
reaction mixture contained 3 mg trypsin per 100 mg hemerythrin. The 
reaction temperature was maintained at 37oc by a Lauda circulator. 
Following the digestion, the solution was acidified to pH 1.5 with 88% 
formic acid to hydrolyze the citraconyl-lysyl bonds. The protein 
solution was shelled in dry'ice-acetone and lyophilized using a Virtis, 
Model 10-020. The lyophilized protein was dissolved by wetting with 
glacial acetic acid, followed by dilution with distilled water to 
approximately 10% acetic acid. The tryptic peptides were separated 
on Sephadex G-50 superfine in 9% formic acid by gel permeation chromate-
graphy. 
One of the tryptic peptides (peptide 50-113) was treated with 
cyanogen bromide to obtain specific cleavage at the COOH-terminus of 
the methionyl residue (13). Approximately 1.0 meq cyanogen bromide 
was reacted with 1.8 µeq methionyl residue in the peptide in 70% formic 
acid for 24 hours. Following the reaction, the material was lyophilized 
and peptides were separated by gel permeation on Sephadex G-50 superfine 
in 9% formic acid. The sample on which amino acid composition was 
determined was subjected to reduction with 30% mercaptoethanol prior to 
l 
I 
CNBr cleavage (-14}. The reduced protein solution was dialyzed against 
increasing concentrations of formic acid (10%, 20%, 70%) to remove 
excess mercaptoethanol and 5 M guanidine hydrochloride. The sample on 
which sequenator analysis was performed was not subjected to reduction 
prior to CNBr cleavage. 
11 
Peptide 50-113 was also subjected to a second TPCK-trypsin digest 
(3 mg trypsin per 50 mg peptide) without prior citraconylation to obtain 
proteolysis at the COOH-terminus of lysyl residues. In the preliminary 
runs, the tryptic hydrolysate was immediately shelled and lyophilized. 
Poor dissolution of the lyophilized protein in the chromatographic 
solvent prompted dialysis against 9% formic acid instead of lyophili-
zation in later runs. The major tryptic peptide from this digestion 
(peptide 54-74) was purified by successive passage through columns of 
Sephadex G-50 and G-25 superfine and Bio-Rad AG 50W-X2. 
SPECTROPHOTOMETRIC ANALYSES 
All spectrophotometric analyses were made using a Cary 14 
spectrophotometer. Matched 1 ml quartz curvettes with a 1 cm path 
length were used. The reference cell contained 9% formic acid. 
Absorbances at 280 nm were used to determine protein concentrations 
and resolve chromatographic fractions at certain key stages of the 
sequence determination. The following extinction coefficients were used: 
apohemerythrin and pyridylethyl hemerythrin, E280 = 2.0 ml/mg; peptide 
50-113, E280 = 2.5 ml/mg; peptide 54-74, E280 = 0.8 ml/mg; peptide 50-62, 
E280 = 0.3 ml/mg, E260 = 3.3 ml/mg. These values were calculated from 
the known composition of tyrosine, tryptophan and pyridylethyl cysteine 
1 
per 13,500 molecular weight subunit (18). Ultraviolet spectra were 
used to identify products from the characteristic absorbance profiles 
of tyrosine, tryptophan and pyridylethylcysteine. 
CHROMATOGRAPHY 
12 
Gel permeation chromatography was performed in glass columns, 
Pharmacia (1.5 x 86 cm) and Kontes Chromaflex (2.5 x 86 cm). The 
mat~ices used were Sephadex G-25 and G-50, superfine grades, purchased 
from Pharmacia and Sigma. The equilibrium and eluant solvent was 9% 
formic acid. Products were generally detected by their absorbances at 
280 nm, although peptide 50-62 was detected by its absorbance at 260 nm. 
Ion exchange chromatography was used to purify tryptic peptide 
54-74 prior to amino acid analysis. The column diameter was 0.6 cm. 
The height of the Bio-Rad AG 50W-X2 resin bed was 56 cm. The column 
temperature was maintained at 47oc. A continuous pH gradient (3.1 to 
5.0) effected column elution. This procedure was done using the method 
and equipment developed by Jones (19). Ion exchange fractions were 
resolved by reaction with ninhydrin (20) and absorbance at 570 nm of the 
Ruhemann 1 s purple complexes. 
AMINO ACID ANALYSIS 
Amino acid analyses (21) were performed on the tryptic peptide 
54-74 and cyanogen bromide peptide 50~62. Each peptide was hydrolyzed 
under vacuum in 6 N HCl at llo0c for 24 hours. The amino acid hydrolysates 
were evaporated to dryness and dissolved in 3.0 ml buffer. Separation 
and detection of the amino acids were done using a Beckman amino acid 
analyzer, Model 120C. Methionine of the CNBr peptide was detected as 
homoserine lactone since the equilibrium between homoserine and the 
lactone is shifted to the lactone on heating in acid. Cysteine was 
detected as the pyridylethylated derivative. 
AMINO ACID SEQUENCE DETERMINATION 
Amino acid sequences were determined for tryptic peptide 50-113 
and CNBr peptide 50-62 using an automated Edman degradation procedure 
and a Beckman Sequencer, Model 890 as described previously (9), but 
modified to improve yields from peptides (22). Sequenator products 
13 
were identified by gas chromatography, thin layer chromatography, and 
spot tests, as described previously (22) and by high-performance liquid 
chromatography (Bio-Analytical Systems, Inc.) as described by Zimmerman, 
et al. (23). 
1 
RESULTS 
The amino acid at position 58 in f_. gouldii hemerythrin was identi-
fied as glutamic acid using specific peptide cleavage techniques in con-
junction with amino acid analysis and automated Edman sequence determin-
ation. Tryptic hydrolysis of citraconylated pyridylethylated hemerythrin 
yielded three peptides (Fig. 2) as observed previously (12). These peptides 
were identified as 50-113, 16-48 and 1-15 in order of decreasing molecular 
weight (12). Since the amino acid composition and manual sequence 
information have already been reported for peptide 50-113 (12), this 
peptide was subjected only to sequenator analysis. The data for peptide 
50-113 are summarized in Table I. Further digestions of peptide 50-113 
and the resulting peptides are shown in Figure 3. Cyanogen bromide 
cleavage yielded peptide 50-62 which was identified by amino acid analysis 
(Table II) and utilized for sequence determination (Table I). Trypsin 
digestion of pyridylethylated 50-113 produced peptide 54-74 which was 
characterized by amino acid analysis (Table II), but was not available 
in sufficient quantity or purity for sequenator analysis. 
PEPTIDE 50-113 
Peptide 50-113 was isolated by Sephadex chromatography of the 
tryptic hydrolysate of citraconylated pyridylethylated hemerythrin. The 
elution pattern (Fig. 2) appears identical to that reported previously (12) 
and fractions from the earliest elution peak 0.45 VT (peptide 50-113) 
were pooled, lyophilized and used for sequenator analysis. The peptide 
15 
0,45 
3.0 
~ 2.0 
~ 
1.0 
PEPTIDE ~ill 
70 llO 
Figure 2. Gel permeation chromatography of trypsin digestion 
products of citraconylated hemerythrin on Sephadex G-50 superfine . 
. A 50 mg sample was applied to the column (1.5 x 86 cm) and 
eluted with 9% formic acid at a flow rate of B ml/hr. Fractions 
were pooled as indicated by horizontal line. Numbers above each 
peak refer to the fraction of the total column volume (Vt) at 
which the material is eluting. Peptide designations are based 
on previous identification (12). 
TABLE I 
SEQUENATOR ANALYSES OF HEMERYTHRIN FRAGMENTSa 
POSITION PEPTIDE 50-113 PEPTIDE 50-62 
PTH DERIVATIVE DETECTIONb PTH DERIVATIVE DETECTIONb 
1 CVS T CYS,ARG H 
2 THR G THR G,H 
3 GLY G GLY G,H 
4 LYS G LYS G,H 
5 . HIS s HIS H 
6 PHE G PHE G,H 
7 Lt:U G LEU G,H 
8 ASN G ASN· G~H 
9 GLU G GLU G,H 
10 GLN G GLN G,H 
11 VAL G VAL H 
12 LEU G LEU H 
13 MET G 
aAt any given position, all amino acids which were unambiguously 
identified are reported, with the exception of amino acids carried 
over from previous steps. Repetitive step-wise yields were 94-97% 
based on quantitation of gas chromatography data. 
bG =gas chromatography (22), H =high-performance-liquid chromato-
graphy (23), S =spot test (22), T =thin layer chromatography (22). 
16 
10 20 
GLY-PHE-PRO-ILE-PRO-ASP-PRO-TYR-VAL-TRP-ASP-PRO-SER-PHE-ARG-TI-R-PHE-TYR-SER-ILE-
30 ~o 
ILE-ASP-ASP-GLU-HIS-LYS-~-LEU-PHE-ASN-GLY-ILE-PHE-HIS-LEU-ALA-ILE-ASP-ASP-ASN-
50 60 
AlJ>.-ASP-ASN-LEU-GLY-GLU-LEU-ARG-ARG-CYS-THR-GLY-LYS-HIS-PHE-LEU-ASN-GLU-GLN-VAL-
-----------1H I... ... ... ... ... ... ... ... ... ... ... 
~ + + + ................... .... 
.---- --------- --
70 80 
LEU-MET-GLN-ALA-SER-GLN-TYR-GLN-PHE-TYR-ASP-GLU-HIS-LYS-LYS-GLU-HIS-GLU-GLY-PHE-
+ .... 
~~r-----------------
90 100 
ILE-HIS-ALA-LEU-ASP-ASN-TRP-LYS-GLY-ASP-VAL-LYS-TRP-ALA-LYS-SER-TRP-LEU-VAL-ASN-
-------------~----~---- ....... --
llO 
HIS-ILE-LYS-Tl-R-ILE-ASP-PHE-LYS-TYR-LYS-GLY-LYS-ILE 
--------------1 
Figure 3. The amino acid sequence off.. gouldii hemerythrin 
as determined by Subramanian, et al. (8) with a change in the 
identification of residues 58 and 59. Peptides were produced 
by specific cleavage of citraconylated hemerythrin with 
trypsin (~),and peptide 50-113 with CNBr (---). Arrows 
indicate region sequ.enced by automated Edman degradations. 
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AMINO 
ACID 
LYS 
HIS 
cysd(b) 
ARG 
ASP+ASN 
THR 
SER 
TABLE II 
AMINO ACID COMPOSITION OF FRAGMENTS GENERATED 
BY TRYPSIN AND CYANOGEN BROMIDE DIGESTION 
OF HEMERYTHRINa 
PEPTIDE 54-74 PEPTIDE 50-62 
GEL PERMEATIONb ION EXCHANGEc 
1.6 (1) 2.0 (1) 0.8 (1) 
2.0 (2) 2.2 (2) 0.8 (1) 
e e 1.0 (1) 
e e 0.1 (0) 
2.0 (2) 2.2 (2) 0.9 (1) 
0.5 (0) 0.4 (0) 0.8 (1) 
1.8 (1) 1.1 (1) 0.4 (0) 
GLU+GLN 4.4 (6) 5.2 (6) 1.6 (2) 
GLY 1.4 (0) 0.9 (0) 1.0 (1) 
ALA 1.3 (1) 1.0 (1) 0.5 (0) 
VAL l.3 (1) 0.9 (1) 1.1 (1) 
METf(c) 0.4 (1) 0.9 (1) 0.8 (1) 
ILE 1.0 (O} 0.3 (0) 0.4 (0) 
LEU 2.0 (2) 1.8 (2) 1. 2 (2) 
TYR 1.3 (2) 1.8 (2) 0.5 (0) 
PHE 1.5 (2) 2.3 (2) 1.2 (1) 
TOTAL 22.5 (21) 23. 0 (21) 12.3 (13) 
aTrypsin and CNBr digests were hydrolyzed in 6 N HC1 at 110 C in 
vacuo for 24 hr and resolved by ion exchange chromatography on 
Bio-Rad AG 50W-X2 resin according to the method of Spackman, 
et al. (21). 
bGel permeation chromatography was done using Sephadex G-50 and 
G-25 superfine with 9% formic acid as solvent. 
clon exchange chromatography on resin cited in a, with e1uent 
pyridine-acetate buffer (19). 
dCysteine was detected as pyridylethyl cysteine. 
eNot determined. 
f Methionine was detected as homoserine lactone in analysis of 
peptide 50-62. 
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-region beginning with cysteine at position 50 was sequenced cleanly 
through methionine 62 (Table I). These data unequivocally positioned 
glutamic acid at residue 58, followed by glutamine at 59. Although the 
sequence of 50-113 answered the original question of position 58 identity, 
subsequent digestions were initiated to yield a·shorter peptide for both 
amino acid composition and sequence determination. 
PEPTIDE 50-62 
Peptide 50-113 was reacted with CNBr and the cleavage products 
were resolved by gel permeation chromatography into a series of peaks 
shown in Figure 4. The peak eluting at 0.62 VT was tentatively assigned 
to contain CNBr peptide 50-62 on the basis of high 260 nm and low 280 nm 
absorbances, expected from the presence of PE-cysteine (16) and the 
absence of tyrosine and tryptophan. Fractions from this peak were 
pooled, lyophilized and subjected to amino acid sequence determination. 
Sequenator analysis (Table I) showed that peptide 50-62 was the major 
component and verified the expected sequence of 12 amino acids beginning 
with cysteine and ending with the penultimate amino acid, leucine. 
Glutamic acid was again clearly identified as residue 58 followed by 
glutamine at 59 (Fig. 5 and 6). The only contaminating peptide apparent 
in the sequencing was peptide 49-62, arising from incomplete trypsin 
cleavage between arginine 49 and cysteine 50. This caused a greater 
amount of carry-over in each sequence cycle than is normally observed. 
A sample of CNBr peptide 50-62 was subjected to amino acid analysis 
(Table II). This material was prepared by reduction of peptide 50-113 
prior to CNBr treatment. The amino acid analysis corroborated the sequence 
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Figure 4. Gel permeation chromatography of CNBr digestion 
products (16 mg) of peptide 50-113 on Sephadex G-50 superfine. 
Conaitions as described in Figure 2. 
20 
(A) 
CYCLE 9, GLU 
ASN GLU 
Figure Sa. Gas-liquid chromatography of PTH-derivative from 
sequenator analysis of peptide 50-62. (A) Glutamic·acid is 
the cycle 9 (residue 58) amino acid. Small carry-over from 
cycles 7 (LEU) and 8 (ASN) are present. 
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~ 
t 
t 
l 
(B) 
CYCLE 10, GLN 
LEU ASN GLN 
Figure Sb. Gas-liquid chromatography of PTH-derivative from 
sequenator analysis of peptide 50-62. (B) Glutamine is the 
cycle 10 (residue 59) amino acid. Intensity of the g1utamic 
acid is characteristic of glutamine: Diminished LEU and ASN 
carry-over are noted. 
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.. "' :I 2 
... "' IO 4 
CYCL!9 CYCLE 10 
Figure 6. High-performance-liquid chromatograms of PTH-
derivatives from sequenator analysis of peptide 50-62. 
Cycle 9 (residue 58) shows glutamic acid as the new peak. 
Overlap of Leu and Asn from cycles 7 and 8, re?pectively, are 
present. Cycle 10 (residue 59) shows a new peak which 
corresponds to glutamine. Leu and Asn carry-over is noticed 
altho~gh the Leu intensity is diminished. 
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obtained for CNBr peptide 50-62. However, serine, a1anine, isoleucine 
and tyrosine occurred to the extent of 0.4-0.5 residue when none was 
anticipated. Thus, some other peptide material must be present, although 
at too low a level to appear in the sequenator analysis. The COOH-
terminus of peptide 50-62, methionine, was modified in the CNBr reaction 
to homoserine lactone which is in equilibrium with homoserine. Acid 
hydrolysis converted all homoserine to the lactone (13) allowing indirect 
methionine quantitation by amino acid analysis. 
The eultion profile of the CNBr hydrolysate (Fig. 4) contained a 
minimum of three earlier eluting peaks other than the one assigned to 
peptide 50-62. The majority of this material is probably the other 
cleavage product, peptide 63-113, in various states of aggregation. 
However, unreacted starting material may also be present. 
PEPTIDE 54-74 
Trypsin digestion of peptide 50-113 cleaved at lysyl residues 
produces a number of smaller fragments which could be partially resolved 
on a Sephadex G-50 superfine column (Fig. 7). The shoulder at 0.69 VT 
was tentatively identified as containing peptide 54-74 on the basis of 
its tyrosine-like ultraviolet spectrum. This spectrum is compared to 
the spectrum of the tryptophan rich starting material and model compounds 
(Fig. 8,9). Fractions exhibiting the tyrosine-rich spectrum were pooled, 
lyophilized and rechromatographed on a Sephadex G-25 superfine column 
(Fig. 10). The material eluting at 0.44 VT was subjected to amino acid 
analysis (Table II). Comparison of the experimental versus expected 
amino acid composition indicated considerable contamination. The remaining 
0.80 
3.0 
2.5 
2.0 
1.5 
1.0 
o.s 
80 100 ]20 140 
VOLL.ME (r.u_) 
figure 7. Gel permeation chromatography of trypsin digestion 
products of peptide 50-113 (48 mg) on Sephadex superfine. 
Conditions as described in Figure 2. 
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Figure 8. Ultraviolet spectra of t. touldii hemerythrin 
peptide 50-.J.13 (A)· and peptide 54-74 B). 
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Fi ure· 9. · Ultrav-folet. spectra of .N-acety1-L-tyrosine ethyl 
ester A) and N-acetyl-DL-tryptophan methyl ester (B) taken 
from (28). 
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;! 
~0.20 
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OH4 
70 80 
VOLll4E VU 
Figure 10. Gel permeation chromatography of peptide 54-74 (5 mg) 
on Sephadex G-25 superfine. Conditions as tlescribed in Figure 2. 
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fractions were pooled and chromatographed on an AG 50W-X2 ion e~change 
column. This significantly improved the.peptide purity as evidenced by 
an amino acid analysis more consistent with the theoretical (Table II). 
However, fractional residues of threonine, lysine, and glycine persisted, 
suggesting incomplete trypsin cleavage at lysine 53, such that a signi-
ficant amount of peptide 50-74 remained in the sample. Subsequently, 
trypsin cleavage was enhanced by inclusion of 2 M urea in the digestion 
reaction. However, the resulting product, peptide 54-74, had reduced 
solubility in pyridine-acetate buffer and precipitated during the ion 
exchange purification. Thus, the insolubility of peptide 54-74 precluded 
its use in amino acid sequence determination. 
DISCUSSION 
Trypsin d~gestion off_. gouldii citraconylated hemerythrin followed 
by gel permeation chromatography yielded peptide 50-113 in sufficient 
quantity and purity for sequenator analysis. The peptide's NH2-terminus 
was cysteine and the amino acid identities were sequentially determined 
as indicated in Table I through methionine at position 62. This sequence 
clearly identified position 58 as glutamic acid. Of importance was 
verification of methionine-62 since its presence allowed an alternative 
specific cleavage procedure of peptide 50-113 with CNBr. Since an amino 
acid sequence determination corroborated by an amino acid composition is 
accepted as being reliable, formation and isolation of peptide 50-62 was 
pursued using CNBr cleavage and gel permeation chromatography. 
Digestion of tryptic peptide 50-113 with CNBr yielded cleavage 
products, peptides 50-62 and 63-113. No detectable advantage was obtained 
from prior mercaptoethanol reduction of peptide 50-113, indicating a low 
occurrence of methionine sulfone and sulfoxide residues. Sequenator 
analysis on the fractions pooled and lyophilized from the 0.62 VT peak 
of Figure 4 unequivocally assigned glutamic acid and glutamine to 
positions 58 and 59, respectively, terminating with the penultimate 
residue at 61, leucine. This sequence is corroborated by amino acid 
analysis which is in good agreement with the expected composition for 
peptide 50-62. 
Purity of peptides 50-113 and 50-62 is evidenced by lack of extra-
neous amino acid peaks in the detection chromatograms, indicating 
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effective cleavage by trypsin and CNBr, respectively, as well as reliable 
chromatographic resolution of the hydrolysates with Sephadex G-50 superfine. 
Attempts at purification and sequence determination of peptide 54-74 
from trypsin digestion of peptide 50-113 were abandoned when the peptide 
precipitated in the pH 3.1 pyridine-acetate ion exchange chromatography 
buffer and. failed to elute from the column. Apparently, the peptide's 
high percentage of hydrophobic residues (57%) confers a peptide confor-
mation unfavorable to dissolution in the polar solvent. The peptide 
would be even less soluble at pH 5, the pH required to elute the peptide 
from the negatively charged column, since it is essentially isoelectric 
at this pH. 
The amino acid sequence determinations of peptides 50-113 and 50-62 
unambiguously identified glutamic acid at position 58 followed by glutamine 
at 59 in f_. gouldii hemerythrin. Use of sequenator analysis coupled with 
direct asparagine and glutamine identification strongly suggests that the 
proposed sequence is correct. The high reliability of our sequencing 
method resides in precise regulation of temperature, reagents and pressure 
at each step of a cycle, enhanced extraction of the thiazolinone inter-
mediate and sensitive detection of the PTH-amino acid derivative by gas-
1 iquid (22) and high-performance-liquid chromatography (23). The greater 
than .95% recovery which is generally achieved in each derivatization, 
cleavage and detection cycle minimizes overlap from adjacent residues, 
making it possible to sequence 30-50 residues of a peptide at a time (22). 
The early position of glutamic acid 58 and glutamic 59 within the first 
10 residues of the peptides which we sequenced lends further credibility 
to our identification. 
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The earlier p_. gouldii hemerythrin sequence which reported the 
reverse order of glutamic acid and glutamine at positions 58 and 59 
utilized a manual Edman degradation in conjunction with older detection 
procedures (12}. Peptide 56-61, whose partial sequence was previously 
reported (18}, was shown to contain 2 of the 3 acidic residues (asp, 
g1u2) in the amidated form on leucine aminopeptidase digestion. The 
manual Edman degradation of peptide 56-61 yielded the sequence, Leu-Asp-
Glu-Glu, according to the amino acid analysis from each cycle following 
alkaline regeneration. Since the amide group is hydrolyzed under alkaline 
conditions, methods that preserve the amides' chemical integrity were 
adopted to determine the presence of glutamine in this region. Peptide 
56-61, generated by chymotrypsin digestion of peptide 50-113, was subjected 
to carboxypeptidase A cleavage. This exopeptidase lacks high specificity 
as indicated in Table III and cleaves from the COCH-terminal until stopped 
by praline or arginine. Glutamic acid is very slowly released by this 
exopeptidase whereas, glutamine is rapidly cleaved. Assignment of position 
59 as glutamic acid (and by inference position 58 as glutamine) resulted 
from the slow appearance of glutamic acid and no glutamine on carboxy-
peptidase A cleavage. More exact kinetic information concerning the rate 
of glutamic acid release was not included in the sequence report. 
The failure of Subramanian and coworkers to observe the release of 
glutamine after treatment could have been due to experimental difficulties 
and should not be considered as definitive evidence for the presence of 
glutamic acid at position 59. The more direct and positive identification 
of glutamic acid at position 58 and glutamine at position 59 by gas-liquid 
and high-performance-liquid chromatography in the present investigation 
TABLE III 
RATES OF HYDROLYSIS OF PEPTIDE SUBSTRATES 
BY CARBOXYPEPTIDASE Aa 
VERY'SLOWc NOT RELEASEDc 
Tyr 
Phe 
Trp 
Leu 
Ile 
Met 
Thr 
Gln 
His 
Ala 
Val 
Asn 
Ser 
Lysb 
Gly 
Asp 
Glu 
CyS03H 
S-carboxymethyl Cys 
Pro 
Arg 
aAdapted from R. P. Ambler, Methods Enzymol., 25, 
262 (1972). Reported by Light (29). 
bThe rate of release of lysine may be influenced by 
the pH of the hydrolysis mixture. 
cThe presence of a "very slow" or "not released" amino 
acid as penultimate residue will generally decrease 
the rate of release of the COOH-terminal amino acid. 
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indicates that the previous1y reported order must have been in error. -
The presence of glutamic acid at position 58 off.. gouldii 
hemerythrin supports the Stenkamp, Sieker and Jensen model (3) for the active 
site of hemerythrin because it shows complete conservation of the amino 
acids proposed as iron ligands in the three proteins which have been com-
pletely sequenced. The identification of glutamic acid as an iron 1igand 
is chemically sensible as the deprotonated carboxyl group at neutral pH 
is capable of electron density donation to the electrophilic iron. Know-
ledge of the iron environment in hemerythrin is important as a potential 
model for oxygen-activating enzymes as well as for industrial development 
or modification to a useful synthetic catalyst. 
CONCLUSIONS 
Knowledge derived from the Stenkamp, Stieker and Jensen active site 
model of T. dyscritum hemerythrin has potentially diverse applications. 
Identification of the iron ligand at position 58 as glutamic acid in 
t· gouldii hemerythrin is, therefore, significant in the support it lends 
to the Stenkamp model. 
Atkins, et al. (24) reported spectral and magnetic similarities 
between hemerythrin's active center and the iron-containing catalytic center 
of ribonucleotide reductase. Use of hemerythrin as a model system may be 
helpful in elucidating the catalytic mechanism of the reductase whose 
biochemical function is reduction of ribonucleotides to their deoxy form. 
Ribonucleotide reductase is a strategic regulatory point in DNA synthesis 
and is under fine feedback control of substrates -and allosteric effectors. 
Agents capable of reductase inhibition are actively sought for their chemo-
therapeutic value. The most effective inhibitory drugs tested in vitro 
have been strong iron chelators, i.e., thiosemicarbazones of 1-formyl-
isoquinoline and 2-formylpyrdine, (25) which would likely interfere with 
general iron metabolism in vivo. Structural information obtaineq from 
hemerythrin's iron active site in conjunction with the reductase's known 
substrate affinity has the potential for yielding a highly specific anti-
cancer drug. 
Use of hemerythrin synthetic analogs may improve the performance and 
longevity of artificial respirators. Currently, a synthetic analog of 
hemoglobin, Collman's tetraphenyl porphyrin picket fence (26), is utilized 
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in respirators but a high affinity for CO leads to poisoning of the analog. 
Since hemerythrin has little affinity for CO, an analog of structural 
design similar to the protein's active site would be medically beneficial. 
Chemical models of oxygen activating proteins are indus.trially 
desirable as catalysts capable of high specificity under mild conditions 
(27). Elucidation of the complex principles underlying oxygen activation 
is a prerequisite for development of a suitable catalyst. This achievement 
will be possible only through the concerted efforts among the diverse 
branches of chemistry. An alternative to the development of synthetic 
catalysts capable of oxygen activation is modification of the protein 
allowing imnobilization on a solid support. Ideally, such a system would 
be amenable to stereoselectivity and large-scale operation. 
. ·· 1 . 
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